Kairos Pharma KAPA Ratios (2023-2025)

NYSE KAPA
$0.29 -0.01 (-1.73%)
As of: Aug 21, 2026 · 9:46 AM EDT
Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Profitability
EBT Margin (Quarter) -4.16%-3.10%-3.23%
EBIT Margin (Quarter) -2.89%-2.53%-2.91%
EBITDA Margin (Quarter) -2.89%-2.53%-2.91%
Operating Margin (Quarter) -2.89%-2.53%-2.91%
Net Margin (Quarter) -4.16%-3.10%-3.23%
FCF Margin (Quarter) -3.61%-1.43%-1.61%
Efficiency
Assets Average (Quarter) 5.39M6.85M7.30M6.61M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -19.13-363.00-17.94-18.50-0.71-2.28-4.40-7.58
Times Interest Earned (Quarter) -19.13-363.00-17.94-18.50-0.71-2.28-4.40-7.58
Valuation
Enterprise Value (Quarter) -0.10M-0.09M-3.22M-1.27M-0.00M-3.03M-4.49M
Return Ratios
Return on Sales (Quarter) 0.00%0.00%0.00%
Return on Capital Employed (Quarter) -53.21%-54.85%-68.65%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%